Order Article Reprints

Codenotti S, Zizioli D, Mignani L, Rezzola S, Tabellini G, Parolini S, Giacomini A, Asperti M, Poli M, Mandracchia D, et al. Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors. Cells. 2022; 11(18):2859. https://doi.org/10.3390/cells11182859

Codenotti, Silvia, Daniela Zizioli, Luca Mignani, Sara Rezzola, Giovanna Tabellini, Silvia Parolini, Arianna Giacomini, Michela Asperti, Maura Poli, Delia Mandracchia, and et al. 2022. "Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors" Cells 11, no. 18: 2859. https://doi.org/10.3390/cells11182859

Codenotti, S., Zizioli, D., Mignani, L., Rezzola, S., Tabellini, G., Parolini, S., Giacomini, A., Asperti, M., Poli, M., Mandracchia, D., Vezzoli, M., Bernardi, S., Russo, D., Mitola, S., Monti, E., Triggiani, L., Tomasini, D., Gastaldello, S., Cassandri, M., ... Fanzani, A. (2022). Hyperactive Akt1 Signaling Increases Tumor Progression and DNA Repair in Embryonal Rhabdomyosarcoma RD Line and Confers Susceptibility to Glycolysis and Mevalonate Pathway Inhibitors. Cells, 11(18), 2859. https://doi.org/10.3390/cells11182859